Your browser doesn't support javascript.
loading
A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
McDermott, David H; Velez, Daniel; Cho, Elena; Cowen, Edward W; DiGiovanna, John J; Pastrana, Diana V; Buck, Christopher B; Calvo, Katherine R; Gardner, Pamela J; Rosenzweig, Sergio D; Stratton, Pamela; Merideth, Melissa A; Kim, H Jeffrey; Brewer, Carmen; Katz, James D; Kuhns, Douglas B; Malech, Harry L; Follmann, Dean; Fay, Michael P; Murphy, Philip M.
Affiliation
  • McDermott DH; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases.
  • Velez D; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases.
  • Cho E; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases.
  • Cowen EW; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
  • DiGiovanna JJ; Laboratory of Cancer Biology and Genetics and.
  • Pastrana DV; Laboratory of Cellular Oncology, National Cancer Institute.
  • Buck CB; Laboratory of Cellular Oncology, National Cancer Institute.
  • Calvo KR; Department of Laboratory Medicine, Clinical Center.
  • Gardner PJ; Office of the Clinical Director, National Institute of Dental and Craniofacial Research.
  • Rosenzweig SD; Department of Laboratory Medicine, Clinical Center.
  • Stratton P; National Institute of Neurologic Disorders and Stroke.
  • Merideth MA; Office of the Clinical Director, National Human Genome Research Institute.
  • Kim HJ; Otolaryngology Branch, National Institute on Deafness and other Communication Disorders, and.
  • Brewer C; Otolaryngology Branch, National Institute on Deafness and other Communication Disorders, and.
  • Katz JD; Rheumatology Fellowship and Training Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland, USA.
  • Kuhns DB; Leidos Biomedical Research Inc., Frederick, Maryland, USA.
  • Malech HL; Laboratory of Clinical Immunology and Microbiology and.
  • Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
  • Fay MP; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
  • Murphy PM; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases.
J Clin Invest ; 133(19)2023 10 02.
Article in En | MEDLINE | ID: mdl-37561579
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Warts / Primary Immunodeficiency Diseases / Heterocyclic Compounds / Immunologic Deficiency Syndromes Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: J Clin Invest Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Warts / Primary Immunodeficiency Diseases / Heterocyclic Compounds / Immunologic Deficiency Syndromes Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: J Clin Invest Year: 2023 Document type: Article Country of publication: